Liver X receptor activation and high-density lipoprotein biology - A reversal of fortune?

被引：10
作者：
Lee, CH
Plutzky, J
机构：
[1] Harvard Univ, Sch Med, Donald Reynolds Ctr Clin Cardiovasc Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
来源：
CIRCULATION | 2006年 / 113卷 / 01期
关键词：
lipids; lipoproteins; liver X receptor; peroxisome proliferator-activated receptors;
D O I：
10.1161/CIRCULATIONAHA.105.590273
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 29 条
[1]   Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters [J].
Berge, KE ;
Tian, H ;
Graf, GA ;
Yu, LQ ;
Grishin, NV ;
Schultz, J ;
Kwiterovich, P ;
Shan, B ;
Barnes, R ;
Hobbs, HH .
SCIENCE, 2000, 290 (5497) :1771-1775
[2]   Increasing HDL cholesterol levels [J].
Brewer, HB .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1491-1494
[3]   KOCHS POSTULATES FOR CHOLESTEROL [J].
BROWN, MS ;
GOLDSTEIN, JL .
CELL, 1992, 71 (02) :187-188
[4]   Muraglitazar, a dual (α/γ) PPAR activator:: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes [J].
Buse, JB ;
Rubin, CJ ;
Frederich, R ;
Viraswami-Appanna, K ;
Lin, KC ;
Montoro, R ;
Shockey, G ;
Davidson, JA .
CLINICAL THERAPEUTICS, 2005, 27 (08) :1181-1195
[5]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]  
CHARWLA A, 2001, MOL CELL, V7, P161
[7]   Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870
[8]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[9]  
DURRINGTON PN, 1995, HYPERLIPIDEMIA
[10]   The ins and outs of reverse cholesterol transport [J].
Groen, AK ;
Elferink, RPJO ;
Verkade, HJ ;
Kuipers, F .
ANNALS OF MEDICINE, 2004, 36 (02) :135-145
123